|
Post by selluwud on Jan 6, 2021 18:12:17 GMT
The Cas-9 and related CRSPR biotech companies have been on fire lately. I own some CRSP & NTLA which got a boost today from successful animal studies treating Progeria which got published today. These methods of genetic treatments hold a ton of potential, but one bad study with unwanted side effects or death would bring them down to earth. I'll ride the good news as long as it keeps coming. I think some buy outs are coming by big pharma.
|
|
|
Post by selluwud on May 13, 2021 14:05:05 GMT
After a sell back in Feb. I bought some CRSP this AM as they have a poster presentation coming soon which I feel will get some attention. Holding my breath.
|
|
|
Post by selluwud on Jun 11, 2021 13:02:53 GMT
|
|
|
Post by JHam on Jun 11, 2021 13:07:12 GMT
Of course it is. Meidas touch
|
|
|
Post by selluwud on Jun 11, 2021 13:13:18 GMT
Of course it is. Meidas touch Ha Ha, funny how I never mention the bad decisions that bomb. LOL
|
|
|
Post by selluwud on Jun 28, 2021 11:10:29 GMT
All the CRISPR based stocks are taking off pre-market due to new developments in trials by Intellia Therapeutics. CRSP rising with the tide along with BEAM
|
|
|
Post by selluwud on Jun 30, 2021 17:12:13 GMT
Rip roaring here today (CRSP) on no new news...........Hmmmmm!
|
|
|
Post by selluwud on Dec 8, 2023 15:56:55 GMT
FDA decision coming today on the heels of MHRA approval in England. I'm holding through next approval review for separate indidcation in the Spring............hopefully with good news today.
|
|